Paul C - Search Results

1

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.

Deneberg S, Grövdal M, Karimi M, Jansson M, Nahi H, Corbacioglu A, Gaidzik V, Döhner K, Paul C, Ekström TJ, Hellström-Lindberg E, Lehmann S. Deneberg S, et al. Among authors: paul c. Leukemia. 2010 May;24(5):932-41. doi: 10.1038/leu.2010.41. Epub 2010 Mar 18. Leukemia. 2010. PMID: 20237504

2

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

Nahi H, Lehmann S, Bengtzen S, Jansson M, Möllgård L, Paul C, Merup M. Nahi H, et al. Among authors: paul c. Leuk Lymphoma. 2008 Mar;49(3):508-16. doi: 10.1080/10428190701861645. Leuk Lymphoma. 2008. PMID: 18297528

3

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks.

Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O, Karimi M, Bengtzén S, Nahi H, Uggla B, Tidefelt U, Höglund M, Paul C, Ekwall K, Döhner K, Lehmann S. Deneberg S, et al. Among authors: paul c. Blood. 2011 Nov 17;118(20):5573-82. doi: 10.1182/blood-2011-01-332353. Epub 2011 Sep 29. Blood. 2011. PMID: 21960591 Free article.

4

The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity.

Lehmann S, Paul C, Törmä H. Lehmann S, et al. Among authors: paul c. Leuk Lymphoma. 2002 Apr;43(4):851-8. doi: 10.1080/10428190290016999. Leuk Lymphoma. 2002. PMID: 12153175

5

The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia.

Möllgård L, Deneberg S, Nahi H, Bengtzen S, Jonsson-Videsäter K, Fioretos T, Andersson A, Paul C, Lehmann S. Möllgård L, et al. Among authors: paul c. Cancer Chemother Pharmacol. 2008 Aug;62(3):439-48. doi: 10.1007/s00280-007-0623-4. Epub 2007 Oct 25. Cancer Chemother Pharmacol. 2008. PMID: 17960382

6

APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.

Ali D, Jönsson-Videsäter K, Deneberg S, Bengtzén S, Nahi H, Paul C, Lehmann S. Ali D, et al. Among authors: paul c. Eur J Haematol. 2011 Mar;86(3):206-15. doi: 10.1111/j.1600-0609.2010.01557.x. Epub 2011 Jan 11. Eur J Haematol. 2011. PMID: 21114538

7

Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML.

Lehmann S, Bengtzen S, Broberg U, Paul C. Lehmann S, et al. Among authors: paul c. Leuk Res. 2000 Jan;24(1):19-25. doi: 10.1016/s0145-2126(99)00153-8. Leuk Res. 2000. PMID: 10634641

8

[Arsenic efficient in acute promyelocytic leukemia].

Lehmann S, Paul C. Lehmann S, et al. Among authors: paul c. Lakartidningen. 1999 Dec 15;96(50):5626-8. Lakartidningen. 1999. PMID: 10643228 Review. Swedish.

9

Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.

Lehmann S, Paul C, Törmä H. Lehmann S, et al. Among authors: paul c. Clin Cancer Res. 2001 Feb;7(2):367-73. Clin Cancer Res. 2001. PMID: 11234892

10

No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.

Hast R, Hellström-Lindberg E, Ohm L, Björkholm M, Celsing F, Dahl IM, Dybedal I, Gahrton G, Lindberg G, Lerner R, Linder O, Löfvenberg E, Nilsson-Ehle H, Paul C, Samuelsson J, Tangen JM, Tidefelt U, Turesson I, Wahlin A, Wallvik J, Winquist I, Oberg G, Bernell P. Hast R, et al. Among authors: paul c. Leukemia. 2003 Sep;17(9):1827-33. doi: 10.1038/sj.leu.2403035. Leukemia. 2003. PMID: 12970783 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,193 results

Search Page

Filters